Search research articles
Contact Us
Filters
Showing results (111-120 of 127) with videos related to
Page
of 13
Sort By:
Neuro-Oncology Advances
|
April 10, 2024
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review
Christopher P Millward, Abdurrahman I Islim, Terri S Armstrong, et al.
Radiology. Imaging Cancer
|
July 15, 2022
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle Study
Fulvio Zaccagna, Mary A McLean, James T Grist, et al.
The New England Journal of Medicine
|
December 16, 2020
Trial of Dexamethasone for Chronic Subdural Hematoma
Peter J Hutchinson, Ellie Edlmann, Diederik Bulters, et al.
Neuro-Oncology
|
March 14, 2022
Opportunities and challenges for the development of "core outcome sets" in neuro-oncology
Christopher P Millward, Terri S Armstrong, Heather Barrington, et al.
BMJ Open
|
May 9, 2022
Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings
Christopher P Millward, Terri S Armstrong, Heather Barrington, et al.
Neuron
|
September 29, 2022
Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells
Harry Bulstrode, Gemma C Girdler, Tannia Gracia, et al.
Acta Neuropathologica
|
February 14, 2013
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations
David E Reuss, Rosario M Piro, David T W Jones, et al.
Journal of Neuro-Oncology
|
July 12, 2018
Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging
Christian F Freyschlag, Sandro M Krieg, Johannes Kerschbaumer, et al.
Cancer Discovery
|
September 8, 2025
Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma
Imran Noorani, Magnus Haughey, Jens Luebeck, et al.
Health Technology Assessment (Winchester, England)
|
March 21, 2024
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)
Peter J Hutchinson, Ellie Edlmann, John G Hanrahan, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 127) with videos related to
Sort By:
Page
of 13
Neuro-Oncology Advances
|
April 10, 2024
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review
Christopher P Millward, Abdurrahman I Islim, Terri S Armstrong, et al.
Radiology. Imaging Cancer
|
July 15, 2022
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle Study
Fulvio Zaccagna, Mary A McLean, James T Grist, et al.
The New England Journal of Medicine
|
December 16, 2020
Trial of Dexamethasone for Chronic Subdural Hematoma
Peter J Hutchinson, Ellie Edlmann, Diederik Bulters, et al.
Neuro-Oncology
|
March 14, 2022
Opportunities and challenges for the development of "core outcome sets" in neuro-oncology
Christopher P Millward, Terri S Armstrong, Heather Barrington, et al.
BMJ Open
|
May 9, 2022
Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings
Christopher P Millward, Terri S Armstrong, Heather Barrington, et al.
Neuron
|
September 29, 2022
Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells
Harry Bulstrode, Gemma C Girdler, Tannia Gracia, et al.
Acta Neuropathologica
|
February 14, 2013
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations
David E Reuss, Rosario M Piro, David T W Jones, et al.
Journal of Neuro-Oncology
|
July 12, 2018
Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging
Christian F Freyschlag, Sandro M Krieg, Johannes Kerschbaumer, et al.
Cancer Discovery
|
September 8, 2025
Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma
Imran Noorani, Magnus Haughey, Jens Luebeck, et al.
Health Technology Assessment (Winchester, England)
|
March 21, 2024
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)
Peter J Hutchinson, Ellie Edlmann, John G Hanrahan, et al.
Page
of 13